Pain Research and Management
Volume 2019 (2019), Article ID 9617280, 6 pages
https://doi.org/10.1155/2019/9617280

Review Article

The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic Headache

Hong Xiao,¹ Baogan Peng,² Ke Ma,³ Dong Huang,⁴ Xianguo Liu,⁵ Yan Lu,⁶ Qing Liu,⁷ Lijuan Lu,⁸ Jingfeng Liu,⁹ Yimei Li,¹⁰ Tao Song,¹¹ Wei Tao,¹² Wen Shen,¹³ Xiaoqiu Yang,¹⁴ Lin Wang,¹⁵ Xiaomei Zhang,¹⁶ Zhigang Zhuang,¹⁷ Hui Liu,¹ and Yanqing Liu¹⁸

¹Department of Algology, West China Hospital of Sichuan University, Chengdu, Sichuan, China
²Department of Orthopedics, General Hospital of Armed Police Force, Beijing, China
³Department of Algology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁴Department of Algology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
⁵Pain Research Center of Sun Yat-Sen University, Guangzhou, Guang Dong, China
⁶Department of Algology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shanxi, China
⁷Department of Algology, The Affiliated T.C.M Hospital of Southwest Medical University, Luzhou, Sichuan, China
⁸Department of Algology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
⁹Department of Algology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
¹⁰Department of Algology, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, China
¹¹Department of Algology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoling, China
¹²Department of Neurosurgery, Shenzhen University General Hospital, Shenzhen, Guangdong, China
¹³Department of Algology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
¹⁴Department of Algology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
¹⁵Department of Algology, The First Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
¹⁶Department of Algology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
¹⁷Department of Algology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
¹⁸Department of Algology, Beijing Tiantan Hospital, Beijing, China

Correspondence should be addressed to Hui Liu; huaxi85423226@126.com and Yanqing Liu; lyqttyy@126.com

Received 18 September 2018; Revised 15 January 2019; Accepted 24 February 2019; Published 1 April 2019

Academic Editor: Fabio Antonaci

Copyright © 2019 Hong Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Cervicogenic headache is a relatively common but unique form of headache, and in China, as well as in several other countries, both diagnosis and a clear evidence-based treatment plan remain controversial. Therefore, the Chinese Association for the Study of Pain organized a meeting of pain management experts and created an expert consensus on the diagnosis and treatment of cervicogenic headache in China. This article summarizes the conclusions of the consensus group regarding the epidemiology, etiology, clinical features, diagnosis, differential diagnosis, treatment, and rehabilitation of cervicogenic headache in China.

1. Introduction

Although cervicogenic headache (CEH) is a common clinical challenge [1–3], controversies still exist regarding its diagnosis and treatment. Therefore, the Chinese Association for the Study of Pain organized a meeting of pain management experts from China to reach consensus on issues surrounding its diagnosis, treatment, and rehabilitation. The group comprised neurologists, orthopedists, and headache specialists. This article reflects the resulting expert consensus on the diagnosis and treatment of CEH in China. Suggestions are also proposed for consideration by headache specialists from other countries.

2. Definition

In 2013, the International Headache Society proposed the most recent definition for CEH [2]. According to this, CEH is defined as any headache caused by a disorder of the cervical spine or its components, such as bone, disc, and/or soft tissue elements, usually, but not invariably, accompanied by neck pain.

3. Diagnostic Criteria

CEH is typically diagnosed based on a detailed history, physical examination, and comprehensive evaluation of the nervous system. Disappearance of headache following a diagnostic block test supports a cervical source of the pain. The diagnostic criteria recommended by the International Classification of Headache Disorders (ICHD) 3rd edition [3] are as follows:

(a)Any headache fulfilling criterion (c)(b)Clinical, laboratory, and/or imaging evidence of a disorder or lesion within the cervical spine or soft tissues of the neck that can cause headache(c)Evidence of causation demonstrated by at least two of the following findings:

(1)Headache has developed in temporal relation to the onset of cervical disorder or appearance of the lesion(2)Headache has significantly improved or resolved along with improvement in or resolution of cervical disorder or lesion(3)Cervical range of motion is reduced, and headache is significantly aggravated by provocative maneuvers(4)Headache disappears after diagnostic block to the suspected cervical spine structure or its supply nerve

(d)Not better accounted for by another ICHD-3 diagnosis

4. Epidemiology

The prevalence of CEH varies in the general population depending on the diagnostic criteria used. However, it has been estimated that 1.0%–4.1% of the population experience CEH [4–6]. Data have revealed that it even ranged to 17.5% in patients with severe headache [7]. Better-controlled and larger-scale epidemiological studies are needed to clarify the true prevalence of CEH.

5. Etiology

5.1. Anatomy

Recent studies have indicated that head and face pain in CEH originate from disorders of the upper cervical nerves (C1–C3) [8]. Indeed, lesions in the atlantooccipital joint, atlantoaxial joint, C2-C3 zygapophyseal joint, and intervertebral disk can all cause occipital pain [9–11]. In contrast, there is no evidence that regions innervated by the lower cervical nerves directly induce headache. Thus, the spinal nerves and branches from C1–C3 are thought to be the main anatomical bases of CEH.

The C1 spinal nerve (suboccipital nerve) innervates the atlantooccipital joint. Pathological change in or damage to this joint may cause pain to be referred in the occipital region. The C2 spinal nerve innervates the atlantoaxial and C2-C3 zygapophyseal joints and is adjacent to the lateral portion of the articular capsule of the C1-C2 zygapophyseal joint (atlantoaxial joint). Pathological changes or injures in these joints or the surrounding tissues can lead to referred pain in the head. The third occipital nerve (C3 medial branch) approaches and dominates the C2-C3 zygapophyseal joint, from where pain can radiate to the occipital, frontal, temporal, and periorbital regions (third occipital neuropathic headache) of the head.

Although the pain resulting from each pathology is not always consistent among patients, the distribution range of pain is typically similar. Neck pain originating near the cranium can radiate to the head, including the frontal and periorbital regions. Conversely, neck pain originating from the pars caudalis of the upper three cervical spines always causes pain in the occipital region. Moreover, a study showed that impairment of the C2-C3 zygapophyseal joint causes CEH in 70% of patients [12], of whom 27% can be diagnosed with third occipital neuropathic headache. Deterioration of the C3-C4 zygapophyseal joints, upper cervical intervertebral discs, and lower cervical zygapophyseal joints are less common causes of CEH.

5.2. Pathophysiology

The pathophysiology of CEH is poorly understood, but it is thought to be a referred pain originating from pathological changes in the upper cervical zygapophyseal joints. As shown in Figure 1 [1], anatomical convergence of pain fibers from the trigeminal nerve (including the ophthalmic division) and the upper three cervical nerves forms the basis for pain to be referred from the upper cervical region to the head, including radiation to the frontal and periorbital regions [13, 14]. The trigeminocervical nucleus receives not only the C1–C3 afferents but also the first branch of the trigeminal sensory afferents, indicating that it receives second-order neuron afferents from the trigeminal and upper three cervical spinal nerves. Therefore, pathological changes in the cervical zygapophyseal joints can generate pain in the areas innervated by either the trigeminal nerve (e.g., frontal and periorbital regions) or the upper three cervical spinal nerves (e.g., occipital and ear regions). Convergence between the trigeminal sensory descending tracts and the upper cervical nerve roots can also cause referred pain in the neck, face, and head.

Figure 1: Mechanism of pain referral from the cervical spine to the head.

6. Clinical Features

6.1. Symptoms

(1)CEH is a chronic unilateral headache; it is also a side-locked headache [15].(2)Pain is first noted in the neck or occipital region before it radiates to the ipsilateral frontotemporal and orbital regions. Temporal regions are the most commonly affected.(3)CEH is usually a deep, blunt, distending, and tense pain without pulsation. The frontotemporal region is the most painful, and the headache is aggravated by neck movements, fatigue, or an unhealthy neck position and relieved by rest.(4)Headache may intermittently occur and last for hours or days, but during the late stages, it can cause persistent pain.(5)Stiffness and a restricted range of motion in the neck may occur and be accompanied by ipsilateral shoulder or arm pain.(6)Most patients also have concomitant symptoms of nausea, tinnitus, dizziness, phonophobia, photophobia, blurred vision, or disordered sleep.

6.2. Physical Examination

Patients with CEH are more likely to have myofascial trigger points on the transverse processes of the second cervical vertebra that can spread to the head and splenius capitis, trapezius, sternocleidomastoid, and suboccipital muscles [16]. Tenderness is observed in the occiput, paravertebral muscles, mastoid process, unilateral or bilateral outlets of the greater occipital nerve, and transverse process of the third cervical vertebra [17]. Patients often present with a limited range of motion of the cervical spine. There is no tenderness of the head and face.

6.3. Investigations

Magnetic resonance imaging (MRI) may show cervical disc degeneration, herniation, or bulging, mostly in the discs of C2–C5. Radiographs may show degenerative changes in the atlantoaxial, zygapophyseal, and uncovertebral joints [18]. However, radiography, MRI, and computed tomography (CT) are typically of limited value in the diagnosis of CEH.

7. Differential Diagnosis

7.1. Primary Headache

Primary headaches can be identified by their typical clinical manifestations [19].

(1)Tension-type headache has the following characteristics: (1) bilateral; (2) pressing or tightening (nonpulsating) pain; (3) paroxysmal pain; (4) not aggravated by routine physical activity; (6) no nausea or vomiting; (7) can be aggravated by compression of the frontal, temporal, masseter, pterygoid, sternocleidomastoid, splenius, and trapezius muscles.(2)Migraine has the following characteristics: (1) unilateral, (2) pulsating pain, (3) headache lasting 4–72 h, (4) aggravation by routine physical activity (e.g., walking or climbing stairs), (5) accompanied by nausea/vomiting/photophobia/phonophobia, (6) ipsilateral premonitory visual symptoms (e.g., flashing, darkness, lines, or blindness), or sensory symptoms (e.g., numbness) lasting >5 min, (7) ergotamine or triptans can be effective, and (8) alleviated by pregnancy.

7.2. Secondary Headaches

(1)Posttraumatic headache can be diagnosed based on its clinical manifestation and MRI and CT findings.(2)Vascular headache, including poststroke, hemangioma, and hypertensive headaches, can be diagnosed based on its clinical manifestation and MRI (including angiography) and CT (including CT or digital subtraction angiography) findings.(3)Headache caused by high or low intracranial pressure. High intracranial pressure is usually caused by tumor or inflammation, which can result in a persistent, nonpulsatile, and severe headache with papilledema and emesis. Low intracranial pressure is usually caused by lumbar puncture, which can be relieved after lying down and aggravated by sitting in an upright posture.(4)Referred headache from skull structures, such as eyes, ears, sinuses, and teeth (e.g., glaucoma, sinusitis, and periodontitis). Specialist examination can aid in the diagnosis, such as intraocular pressure determination, sinus CT, and dental examination.(5)Somatoform disorders should also be considered. Physical and auxiliary examinations are normal in these patients. Repeated and changing physical symptoms are presented, and pain areas are not fixed. The patient may also have anxiety and depression.

8. Treatment

8.1. Pharmacotherapy

Despite a lack of convincing clinical studies on effective medications for CEH, pharmacotherapy remains among the best available treatments [20, 21]. Several types of medications are commonly used [22, 23]:

(1)Nonsteroidal anti-inflammatory drugs (NSAIDs) can be effective, including nonselective COX and selective COX-2 inhibitors.(2)Muscle relaxants, particularly tizanidine, baclofen, and eperisone hydrochloride, that have central mechanisms of action can also provide analgesic effects in both the acute phase and for prevention. Tizanidine can be combined with NSAIDs because of its gastroprotective effect and good safety.(3)Antiepileptic drugs and antidepressants can be used in patients with neuropathic pain. Common drugs for this purpose include gabapentin, pregabalin, amitriptyline, venlafaxine, and duloxetine.

8.2. Injection to the Atlantoaxial and C2-C3 Zygapophyseal Joints and Nerve Block

Individualized injection therapy can be selected according to the pain’s location and characteristics. These procedures are associated with risks of structural damage from needle placement but can also result in the injection of local anesthetic into the vertebral artery, high-level epidural anesthesia, total spinal cord anesthesia, or injury of the spinal cord and nerve roots. Nonparticulate, water-soluble steroid hormones are recommended to prevent the embolism of steroid hormone particles.

8.2.1. Joint Injection

(1) Atlantoaxial Joint Injection. This can benefit patients with suboccipital or occipital pain aggravated by cervical rotation [24] or pain due to inflammatory stimuli [25]. Intraarticular injection can use a lateral or posterior approach and should be slow, with the volume not exceeding 1 ml. One study has shown that injection to the atlantoaxial joint was effective in 81.2% of cases. After 3 months’ follow-up, 20% of patients had pain relief exceeding 50% [26].

(2) C2-C3 Zygapophyseal Joint Injection. This injection can be considered for patients with upper neck pain spreading to the occipital region or pain that increases when the neck is rotated or back is stretched. During the procedure, the head can be rotated for a better field of vision. Again, the injection should be slow and should not exceed a total volume of 1 ml. However, the therapeutic efficacy of C2-C3 intra-articular injection remains controversial [27–29].

8.2.2. Nerve Block

(1) Cervical Spinal Nerve Root Block. Selective nerve root injection could be used in patients with cervical spondylotic radiculopathy although the depth of the needle should be monitored to prevent complications. The effectiveness of this method is 70%, with 50% still reporting relief after 12 months [30].

(2) Third Occipital Nerve Block. This block can be used to diagnose CEH and predict the efficacy of radiofrequency treatment.

(3) Occipital Nerve Block. This block can be used to diagnose and treat occipital pain [21]. Clinically, occipital nerve injection can be repeatedly and intermittently used for symptomatic treatment. Dose for diagnostic injection should be limited to 2 ml; however, when it reaches 3–5 ml, the greater and small occipital nerves are completely blocked.

8.3. Minimally Invasive Interventional Management

Radiofrequency therapy, including radiofrequency thermocoagulation and pulse radiofrequency, is minimally invasive interventional techniques. Nerve properties can be distinguished by monitoring the stimulation frequency and impedance. Interventional radiofrequency therapy can be considered if a diagnostic nerve block is effective [31].

Radiofrequency intervention is recommended for patients with intractable cervical headache from the C2-C3 zygapophyseal joint for which conservative treatment has failed and complete relief has been obtained from a diagnostic nerve block [13]. The efficacy for CEH of other origins needs to be confirmed. Pulse radiofrequency is a type of neuromodulation therapy that has shown satisfactory short-term efficacy, albeit with recurrence during long-term follow-up that requires repeated treatments [32]. The reason for poor performance of C2 ganglion pulse radiofrequency treatment in some patients may be occipital pain from the C1 and C3 spinal nerve branches through the superior cervical plexus. Percutaneous laser disc decompression is another effective minimally invasive procedure for patients with cervical disc herniation, protrusion, or disc degeneration who have neck and shoulder pain with nerve root symptoms. Also, plasma radiofrequency can be considered when other methods fail to achieve satisfactory results by reducing the volume of the nucleus pulposus, potentially improving symptoms.

Finally, ozone has strong anti-inflammatory and analgesic effects that can benefit patients in whom glucocorticoid use is contraindicated. Its efficacy can be further improved through combination with a nerve block. Clinical effectiveness of percutaneous radiofrequency ablation combined with ozone is superior to that of percutaneous radiofrequency ablation alone in the treatment of cervical disc herniation, providing better medium- and long-term outcomes. Percutaneous laser disc decompression, ozone therapy, and other techniques have shown some clinical efficacy.

8.4. Surgical Procedures

Surgery is not usually recommended for CEH, except when CEH is refractory and does not respond to noninvasive treatment, and there is convincing evidence that CEH is caused by pathological changes amenable to surgical treatment. Surgery may be beneficial for three specific causes of CEH as follows: (1) C2 spinal nerve compression by vascular/ligamentous structures, (2) osteoarthritis of the lateral atlantoaxial joint, and (3) upper cervical intervertebral disc pathology [33].

8.5. Physical Therapy

Physiotherapy is almost universally available and risk-free and has enormous benefits [34–36], such as reducing the frequency of CEH and improving headaches in the long-term. In view of the noninvasive nature of physiotherapy, it is recommended that it be the first choice for patients with CEH. Options include manipulation therapy (e.g., pulling, relaxation, and chiropractic), specific training therapy (e.g., static and dynamic stretching and training), and low-load endurance muscle exercise focusing on the neck and shoulder joints or the upper limbs (moderately strong evidence) [37–39]. In the initial stages, the muscles are gently stretched and artificial neck traction is performed to make physical therapy easier for the patient. Next, strength training and aerobic exercise are gradually introduced according to the patient’s tolerance. High-velocity manipulation is not recommended because of the risk of interregional arterial dissection and stroke.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

All the authors prepared and drafted part of Chinese version of the manuscript. Hong Xiao and Baogan Peng drafted the English version of the manuscript; Hui Liu and Yanqing Liu reviewed and revised the manuscript. All authors read and approved the final manuscript.

References

N. Bogduk and J. Govind, “Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment,” The Lancet Neurology, vol. 8, no. 10, pp. 959–968, 2009.

Headache Classification Committee of the International Headache Society (IHS), “The international classification of headache disorders, 3rd edition (beta version),” Cephalalgia, vol. 33, no. 9, pp. 629–808, 2013.

Headache Classification Committee of the International Headache Society (IHS), “The international classification of headache disorders, 3rd edition,” Cephalalgia, vol. 38, no. 1, pp. 1–211, 2018.

O. Sjaastad and L. S. Bakketeig, “Migraine without aura: comparison with cervicogenic headache: Vågå study of headache epidemiology,” Acta Neurologica Scandinavica, vol. 117, no. 3, pp. 173–180, 2008.

H. Knackstedt, D. Bansevicius, K. Aaseth, R. B. Grande, C. Lundqvist, and M. B. Russell, “Cervicogenic headache in the general population: the akershus study of chronic headache,” Cephalalgia, vol. 30, no. 12, pp. 1468–1476, 2010.

K. Shimohata, K. Hasegawa, O. Onodera, M. Nishizawa, and T. Shimohata, “The clinical features, risk factors, and surgical treatment of cervicogenic headache in patients with cervical spine disorders requiring surgery,” Headache: The Journal of Head and Face Pain, vol. 57, no. 7, pp. 1109–1117, 2017.

S. Evers, “Comparison of cervicogenic headache with migraine,” Cephalalgia, vol. 28, no. 1, pp. 16-17, 2008.

C. A. Odonkor, T. Tang, D. Taftian, and A. Chhatre, “Bilateral intra-articular radiofrequency ablation for cervicogenic headache,” Case Reports in Anesthesiology, vol. 2017, Article ID 1483279, 6 pages, 2017.

K. P. Schellhas, M. D. Smith, C. R. Gundry, and S. R. Pollei, “Cervical discogenic pain. Prospective correlation of magnetic resonance imaging and discography in asymptomatic subjects and pain sufferers,” Spine, vol. 21, no. 3, pp. 300–311, 1996.

S. Armijo-Olivo and D. Magee, “Cervical musculoskeletal impairments and temporomandibular disorders,” Journal of Oral and Maxillofacial Research, vol. 3, no. 4, p. e4, 2013.

E. Wang and D. Wang, “Treatment of cervicogenic headache with cervical epidural steroid injection,” Current Pain and Headache Reports, vol. 18, no. 9, p. 442, 2014.

A. Dwyer, C. Aprill, and N. Bogduk, “Cervical zygapophyseal joint pain patterns. I: a study in normal volunteers,” Spine, vol. 15, no. 6, pp. 453–457, 1990.

V. R. Nagar, P. Birthi, J. S. Grider, and A. Asopa, “Systematic review of radiofrequency ablation and pulsed radiofrequency for management of cervicogenic headache,” Pain Physician, vol. 18, no. 2, pp. 109–130, 2015.

J. J. Liu, G. Cadena, R. R. Panchal, R. J. Schrot, and K. D. Kim, “Relief of cervicogenic headaches after single-level and multilevel anterior cervical diskectomy: a 5-year post hoc analysis,” Global Spine Journal, vol. 6, no. 6, pp. 563–570, 2016.

O. Sjaastad, T. A. Fredriksen, and V. Pfaffenrath, “Cervicogenic headache: diagnostic criteria,” Headache: The Journal of Head and Face Pain, vol. 38, no. 6, pp. 442–445, 1998.

J. Rubio-Ochoa, J. Benítez-Martínez, E. Lluch, S. Santacruz-Zaragozá, P. Gómez-Contreras, and C. E. Cook, “Physical examination tests for screening and diagnosis of cervicogenic headache: a systematic review,” Manual Therapy, vol. 21, pp. 35–40, 2016.

T. Hall, K. Briffa, D. Hopper, and K. Robinson, “Reliability of manual examination and frequency of symptomatic cervical motion segment dysfunction in cervicogenic headache,” Manual Therapy, vol. 15, no. 6, pp. 542–546, 2010.

A. Frese and S. Evers, “Biological markers of cervicogenic headache,” Cephalalgia, vol. 28, no. 1, pp. 21–23, 2008.

M.-E. R. Aguila, T. Rebbeck, K. G. Mendoza, M.-G. L. De La Peña, and A. M. Leaver, “Definitions and participant characteristics of frequent recurrent headache types in clinical trials: a systematic review,” Cephalalgia, vol. 38, no. 4, pp. 786–793, 2018.

S. Haldeman and S. Dagenais, “Cervicogenic headaches: a critical review,” The Spine Journal, vol. 1, no. 1, pp. 31–46, 2001.

D. M. Biondi, “Cervicogenic headache: a review of diagnostic and treatment strategies,” Journal of the American Osteopathic Association, vol. 105, no. 2, pp. 16S–22S, 2005.

H. van Suijlekom, J. Van Zundert, S. Narouze, M. van Kleef, and N. Mekhail, “6. Cervicogenic headache,” Pain Practice, vol. 10, no. 2, pp. 124–130, 2010.

C. Fernández-de-las-Peñas and M. L. Cuadrado, “Therapeutic options for cervicogenic headache,” Expert Review of Neurotherapeutics, vol. 14, no. 1, pp. 39–49, 2014.

G. Ehni and B. Benner, “Occipital neuralgia and the C1-2 arthrosis syndrome,” Journal of Neurosurgery, vol. 61, no. 5, pp. 961–965, 1984.

J. Glémarec, P. Guillot, Y. Laborie, J. M. Berthelot, A. Prost, and Y. Maugars, “Intraarticular glucocorticosteroid injection into the lateral atlantoaxial joint under fluoroscopic control. A retrospective comparative study in patients with mechanical and inflammatory disorders,” Joint Bone Spine, vol. 67, no. 1, pp. 54–61, 2000.

S. N. Narouze, J. Casanova, and N. Mekhail, “The longitudinal effectiveness of lateral atlantoaxial intra-articular steroid injection in the treatment of cervicogenic headache,” Pain Medicine, vol. 8, no. 2, pp. 184–188, 2007.

L. Barnsley, S. M. Lord, B. J. Wallis, and N. Bogduk, “Lack of effect of intraarticular corticosteroids for chronic pain in the cervical zygapophyseal joints,” New England Journal of Medicine, vol. 330, no. 15, pp. 1047–1050, 1994.

C. W. Slipman, J. S. Lipetz, C. T. Plastaras, H. B. Jackson, S. T. Yang, and A. M. Meyer, “Therapeutic zygapophyseal joint injections for headaches emanating from the C2-3 joint,” American Journal of Physical Medicine & Rehabilitation, vol. 80, no. 3, pp. 182–188, 2001.

L. Zhou, Z. Hud-Shakoor, C. Hennessey, and A. Ashkenazi, “Upper cervical facet joint and spinal rami blocks for the treatment of cervicogenic headache,” Headache: The Journal of Head and Face Pain, vol. 50, no. 4, pp. 657–663, 2010.

L. C. G. Persson, J. Y. Carlsson, and L. Anderberg, “Headache in patients with cervical radiculopathy: a prospective study with selective nerve root blocks in 275 patients,” European Spine Journal, vol. 16, no. 7, pp. 953–959, 2007.

J. F. Hamer and T. A. Purath, “Response of cervicogenic headaches and occipital neuralgia to radiofrequency ablation of the C2 dorsal root ganglion and/or third occipital nerve,” Headache: The Journal of Head and Face Pain, vol. 54, no. 3, pp. 500–510, 2014.

T. Gabrhelík, P. Michálek, and M. Adamus, “Pulsed radiofrequency therapy versus greater occipital nerve block in the management of refractory cervicogenic headache: a pilot study,” Prague Medical Report, vol. 112, no. 4, pp. 279–287, 2011.

R. J. Schrot, J. S. Mathew, Y. Li, L. Beckett, H. W. Bae, and K. D. Kim, “Headache relief after anterior cervical discectomy: post hoc analysis of a randomized investigational device exemption trial,” Journal of Neurosurgery: Spine, vol. 21, no. 2, pp. 217–222, 2014.

G. Jull, P. Trott, H. Potter et al., “A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache,” Spine, vol. 27, no. 17, pp. 1835–1843, 2002.

T. M. Kay, A. Gross, C. Goldsmith, P. L. Santaguida, J. Hoving, and G. Bronfort, “Exercises for mechanical neck disorders,” Cochrane Database of Systematic Reviews, vol. 1, p. CD004250, 2005.

T. Hall, H. T. Chan, L. Christensen, B. Odenthal, C. Wells, and K. Robinson, “Efficacy of a C1-C2 self-sustained natural apophyseal glide (SNAG) in the management of cervicogenic headache,” Journal of Orthopaedic & Sports Physical Therapy, vol. 37, no. 3, pp. 100–107, 2007.

C. Fernández-de-las-Peñas and M. L. Cuadrado, “Physical therapy for headaches,” Cephalalgia, vol. 36, no. 12, pp. 1134–1142, 2016.

A. R. Gross, J. P. Paquin, G. Dupont et al., “Exercises for mechanical neck disorders: a Cochrane review update,” Manual Therapy, vol. 24, pp. 25–45, 2016.

S. Sahrmann, D. C. Azevedo, and L. V. Dillen, “Diagnosis and treatment of movement system impairment syndromes,” Brazilian Journal of Physical Therapy, vol. 21, no. 6, pp. 391–399, 2017.